RightFit Trial Directory

Breast Cancer clinical trials in Columbus, OH

32 recruiting breast cancer studies with a site in Columbus, OH.

All trials in Columbus, OH · All Breast Cancer trials

RecruitingPhase 3NCT07391774

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI)

Canton, OH · Centerville, OH · Columbus, OH · +200 more sites

RecruitingPhase 1NCT06120283

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Sponsor: BeOne Medicines

Columbus, OH · +8 more sites

RecruitingPhase 1NCT07310420

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Sponsor: TerSera Therapeutics LLC

Cleveland, OH · Columbus, OH · +24 more sites

RecruitingPhase 2NCT06749210

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH · +1 more sites

RecruitingPhase 3NCT07174336

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Sponsor: Eli Lilly and Company

Akron, OH · Canton, OH · Cleveland, OH · +126 more sites

RecruitingPhase 1 / Phase 2NCT05579366

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Sponsor: Genmab

Columbus, OH · +36 more sites

RecruitingPhase 1 / Phase 2NCT06657222

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Sponsor: Gilead Sciences

Cleveland, OH · Columbus, OH · +11 more sites

RecruitingPhase 3NCT05379153

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Sponsor: Alliance for Clinical Trials in Oncology

Columbus, OH · +1 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Akron, OH · Alliance, OH · +1223 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Akron, OH · Athens, OH · Avon, OH · +825 more sites

RecruitingPhase 2NCT06195306

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Sponsor: National Cancer Institute (NCI)

Columbus, OH · +2 more sites

RecruitingPhase 3NCT06748222

E-Mindfulness Approaches for Living After Breast Cancer

Sponsor: NRG Oncology

Beavercreek, OH · Cincinnati, OH · Columbus, OH · +378 more sites

RecruitingPhase 2NCT05467891

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Sponsor: Oana Danciu

Columbus, OH · +20 more sites

RecruitingPhase 1 / Phase 2NCT05768139

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Sponsor: Eli Lilly and Company

Cleveland, OH · Columbus, OH · +26 more sites

RecruitingPhase 4NCT06169371

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Sponsor: University of Illinois at Chicago

Columbus, OH · +2 more sites

RecruitingNot applicableNCT07447700

A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH

RecruitingNot applicableNCT05677802

Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Sponsor: Ohio State University Comprehensive Cancer Center

Cleveland, OH · Columbus, OH

RecruitingPhase 1NCT07046923

A Study of LY4175408 in Participants With Advanced Cancer

Sponsor: Eli Lilly and Company

Columbus, OH · +14 more sites

RecruitingPhase 3NCT05696626

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Sponsor: LeonaBio

Cleveland, OH · Columbus, OH · +33 more sites

RecruitingPhase 2NCT06917313

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Sponsor: Yale University

Columbus, OH · +1 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Akron, OH · Avon, OH · +809 more sites

RecruitingPhase not listedNCT03448926

The PREDICT Registry:

Sponsor: PreludeDx

Akron, OH · Cleveland, OH · Columbus, OH · +27 more sites

RecruitingPhase not listedNCT04022616

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH

RecruitingNot applicableNCT07386444

Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH

RecruitingPhase 1 / Phase 2NCT06395519

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Sponsor: 858 Therapeutics, Inc.

Columbus, OH · +13 more sites

RecruitingPhase 1 / Phase 2NCT06943521

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Sponsor: Tanabe Pharma America, Inc.

Columbus, OH · +3 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Akron, OH · Alliance, OH · Barberton, OH · +952 more sites

RecruitingNot applicableNCT05984888

Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH

RecruitingPhase 1 / Phase 2NCT06827613

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

Sponsor: Marengo Therapeutics, Inc.

Columbus, OH · +5 more sites

RecruitingPhase 1 / Phase 2NCT06682793

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Sponsor: A2 Biotherapeutics Inc.

Columbus, OH · +9 more sites

RecruitingNot applicableNCT05349227

Comprehensive Outcomes for After Cancer Health

Sponsor: Pack Health

Columbus, OH · +6 more sites

Not yet recruitingPhase 1 / Phase 2NCT07217990

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.